)
Elementis (ELM) investor relations material
Elementis H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved strong profit growth and margin expansion despite a soft demand environment and slight revenue decline, demonstrating business resilience and quality.
Completed strategic divestments of Talc and Chromium, transforming into a pure-play specialty chemicals business focused on personal care and coatings, and acquired Alchemy Ingredients.
Announced sale of the pharmaceutical business to ABF for ~$40m, further sharpening strategic focus and expected to uplift 2025 group operating margins.
Launched the Elevate Elementis strategy, targeting mid-single-digit revenue growth, >23% operating margins, and >90% three-year operating cash conversion, with innovation sales rising to 16.4%.
Achieved zero lost time accidents and significantly reduced carbon footprint by nearly 80% since 2019, including a 77% reduction in carbon intensity.
Financial highlights
Adjusted operating profit grew 4.6% to $126.7 million, with a 150 basis point margin improvement to 21.2%.
Adjusted EPS increased 14.2% to $0.137, aided by lower net finance costs and share buyback.
Group revenue declined 1.9% year-over-year to $597.5 million, with coatings volumes down but personal care volumes up.
Free cash flow was $41 million, down from $51 million, due to working capital outflow and higher CapEx.
Net debt ended at $185.4 million, with net debt/EBITDA at 1.3x after acquisitions and shareholder returns.
Outlook and guidance
Confident in delivering organic growth through R&D, customer intimacy, best-in-class service, and operational efficiency in 2026.
New mid-term targets: mid-single-digit revenue growth, operating margin above 23%, operating cash conversion above 90%, and ROCE above 30%.
2026 guidance: capex at 4-5% of revenue, net finance costs ~$20m, effective tax rate ~25%.
Board recommended a final dividend of GBP 0.03, full year up 7.5% to GBP 0.043 (31% payout ratio).
Proceeds from pharma business sale expected to be distributed to shareholders upon completion.
- Adjusted profit up 24%, margin at 17%, and Talc review after $66m impairment.ELM
H1 20242 Feb 2026 - Adjusted operating profit and margins improved year-over-year, with strong cash flow and strategic actions.ELM
Q4 2025 TU21 Jan 2026 - Strong 2024 growth, margin expansion, and cost savings position for 2026 targets.ELM
H2 20242 Dec 2025 - Talc business sold for $121m, enabling $50m buyback and sharper specialty focus.ELM
Investor Update21 Nov 2025 - Adjusted profit and margins up, net debt down, and $50m buyback supports strong outlook.ELM
H1 202516 Nov 2025 - Q3 revenue up 2% year-over-year, guidance maintained, and key leadership transitions announced.ELM
Trading Update29 Oct 2025 - Resilient Q3 performance, steady margins, and full-year guidance reaffirmed.ELM
Trading Update13 Jun 2025 - Profit and margin growth achieved amid weak demand; cost savings and outlook on track.ELM
Trading Update6 Jun 2025
Next Elementis earnings date
Next Elementis earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)